Moderna’s COVID-19 vaccine sales in the third quarter disappoint investors, and its stock takes a hit
November 04, 2021 at 14:56 PM EDT
It appears that Pfizer has taken the lead in the tug of war for market share among the leading COVID-19 vaccine makers, and Moderna's investors aren't happy about it.
